ArticleContemporary clinical trials communications2019

A descriptive research: Exclusion from submitted clinical data package in the review process of new drug approval due to GCP violation in Japan.

Ryuta Asada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.